.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Union Health Minister J.P. Nadda recently addressed concerns regarding the India Rabies Vaccine Supply. He confirmed that the nation maintains an adequate inventory of Anti-Rabies Vaccine (ARV) and Rabies Immunoglobulin (RIG). Consequently, current production levels significantly exceed the annual domestic demand for these life-saving treatments.
Minister Nadda highlighted that India possesses an annual production capacity of approximately 8.17 crore vials of ARV. Additionally, manufacturers produce about 1.77 crore vials of RIG each year. However, the annual requirement is considerably lower. Specifically, India records around 58 lakh animal bite cases annually, including 47 lakh dog bites. Therefore, the country maintains a massive surplus and continues to export these vaccines globally.
State governments hold the primary responsibility for distributing vaccines within their regions. Under the National Rabies Control Programme (NRCP), the central government provides necessary technical and financial support. Furthermore, the National Health Mission (NHM) allocates funds to ensure an uninterrupted supply chain. Moreover, a real-time tracking system helps officials monitor stocks effectively across all states. The Ministry also issues regular advisories to prevent any potential local shortages. Because rabies is a fatal virus, the government prioritizes immediate access to post-exposure prophylaxis.
Q1: Is there a shortage of anti-rabies vaccines in India?
No. Union Health Minister J.P. Nadda confirmed that India has a surplus of both ARV and RIG, with production far outstripping domestic needs.
Q2: Who is responsible for vaccine distribution in India?
Health is a state subject. Therefore, individual state and UT governments manage the procurement and distribution of these vaccines using central funds.
Q3: How many animal bite cases are reported in India annually?
India reports approximately 58 lakh animal bite cases per year. Dog bites account for about 47 lakh of these total cases.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
J.P. Nadda confirms India Rabies Vaccine Supply is stable. Annual production of 8.17 crore vials far exceeds the demand from 58 lakh animal bite cases....
6 months ago
As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
